FineHeart is very proud to be part of the Agence de l’innovation en santé 2023-2025 roadmap!
FineHeart is very proud to be part of the Agence de l'innovation en santé 2023-2025 roadmap!
This selection alongside innovative HealthTech companies reinforces our commitment to playing a part in the future of medicine and our healthcare system.
FLOWMAKER has been authorised to start clinical trials. More than ever, it represents a huge hope for more than 200,000 patients who, every year, cannot benefit from current therapeutic solutions.